Gary L. Crocker files SEC Form 4 disclosures for MERRIMACK PHARMACEUTICALS INC. They have made 44 open-market trades across 1 company since 2012, most recently 2023-08-11.
CIK 0001094201
43 open-market purchases totalling $3.8M since 2012, against 1 sale. Across 43 scored buys the stock is down 3.3% at ninety days, and 2.6 points behind the S&P over the same stretch.
43 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MACK | 133,105 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2023-08-14 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 37% | 67% | 47% |
| Avg Move | -2.4% | +5.5% | -3.3% |
| Alpha | -1.3% | +6.0% | -2.6% |
| Scored | 43 | 43 | 43 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MACK | BUY | 2023-08-10 | 2023-08-14 | $12.48 | $50K | -1.5% | -0.6% | +0.5% |
| MACK | BUY | 2022-06-09 | 2022-06-13 | $5.15 | $23K | +14.3% | +14.8% | -14.5% |
| MACK | BUY | 2022-06-07 | 2022-06-09 | $5.10 | $3K | +19.1% | +17.5% | -13.9% |
| MACK | BUY | 2022-05-24 | 2022-05-26 | $5.09 | $13K | -5.3% | +8.4% | -23.5% |
| MACK | BUY | 2022-05-19 | 2022-05-23 | $5.04 | $3K | -8.5% | +10.7% | -24.4% |
| MACK | BUY | 2022-05-17 | 2022-05-19 | $5.08 | $27K | -5.3% | +19.1% | -20.6% |
| MACK | BUY | 2022-05-12 | 2022-05-16 | $5.04 | $12K | +10.8% | +9.2% | -17.3% |
| MACK | BUY | 2022-04-21 | 2022-04-25 | $6.00 | $30K | -0.4% | -5.2% | -7.3% |
| MACK | BUY | 2022-03-30 | 2022-04-01 | $6.19 | $3K | -2.4% | -10.8% | -6.7% |
| MACK | BUY | 2022-03-28 | 2022-03-29 | $6.16 | $31K | +7.4% | -8.0% | -5.4% |
| MACK | BUY | 2022-03-22 | 2022-03-24 | $6.11 | $2K | +0.8% | -9.9% | -4.9% |
| MACK | BUY | 2022-03-15 | 2022-03-17 | $6.14 | $29K | -7.8% | -10.1% | -16.4% |
| MACK | BUY | 2022-03-11 | 2022-03-15 | $6.05 | $61K | -0.8% | -0.6% | -17.6% |
| MACK | BUY | 2022-02-18 | 2022-02-23 | $5.96 | $20K | -2.3% | +3.5% | -14.4% |
| MACK | BUY | 2022-02-16 | 2022-02-18 | $6.17 | $80K | -1.0% | +0.0% | -15.2% |
| MACK | BUY | 2022-02-14 | 2022-02-16 | $5.98 | $11K | +3.5% | +11.0% | -15.8% |
| MACK | BUY | 2022-01-27 | 2022-01-31 | $4.60 | $3K | +21.5% | +20.2% | +8.4% |
| MACK | BUY | 2022-01-26 | 2022-01-27 | $4.56 | $14K | +22.2% | +33.0% | +22.0% |
| MACK | BUY | 2022-01-21 | 2022-01-25 | $4.40 | $40K | +39.7% | +34.7% | +18.5% |
| MACK | BUY | 2022-01-18 | 2022-01-20 | $4.54 | $23K | +15.1% | +39.2% | +24.3% |
| MACK | BUY | 2022-01-13 | 2022-01-18 | $4.47 | $45K | +1.5% | +27.3% | +29.9% |
| MACK | BUY | 2022-01-11 | 2022-01-13 | $4.18 | $42K | +15.5% | +40.5% | +44.9% |
| MACK | BUY | 2021-04-12 | 2021-04-14 | $6.07 | $6K | +9.4% | -6.8% | -12.9% |
| MACK | BUY | 2021-04-09 | 2021-04-12 | $6.10 | $7K | +20.3% | -2.9% | +1.1% |
| MACK | BUY | 2021-04-07 | 2021-04-09 | $6.19 | $13K | +25.3% | -2.6% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.